(Q47965516)

7 February 2018

editorial

0 references

title

Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies (English)

1 reference

7 February 2018

main subject

cerebral malaria

0 references

malaria

0 references

cognitive dysfunction

1 reference

Guy A Zimmerman

1

1 reference

7 February 2018

Hugo Castro-Faria-Neto

series ordinal

2

1 reference

7 February 2018

publication date

1 November 2010

1 reference

7 February 2018

Expert Review of Anti-infective Therapy

published in

1 reference

7 February 2018

volume

8

1 reference

7 February 2018

issue

11

1 reference

7 February 2018

page(s)

1209-1212

1 reference

7 February 2018

That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Estimating the global clinical burden of Plasmodium falciparum malaria in 2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Artesunate for the treatment of severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Conventional and experimental treatment of cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Developmental impairments following severe falciparum malaria in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Cognitive impairment after cerebral malaria in children: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Cerebral malaria in children is associated with long-term cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

21 January 2018

Seizures in rural Zambia

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Differentiating the pathologies of cerebral malaria by postmortem parasite counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Cerebral malaria: in praise of epistemes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

The murine cerebral malaria phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Oxidative stress and rheology in severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Murine cerebral malaria: how far from human cerebral malaria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Neuropathogenesis of human and murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Antioxidant treatment prevented late memory impairment in an animal model of sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Murine cerebral malaria: the whole story

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Cerebral malaria: human versus mouse studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Can erythropoietin be used to prevent brain damage in cerebral malaria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.117

21 January 2018

Identifiers

DOI

10.1586/ERI.10.117

1 reference

7 February 2018

release_imxuzpqkqrfzjfyqs2ze3pkd4q

Fatcat ID

0 references

1 reference

7 February 2018